Literature DB >> 23709307

The impact of pseudomembrane formation on the outcome of Clostridium difficile-associated disease.

T Berdichevski1, N Keller, G Rahav, S Bar-Meir, R Eliakim, S Ben-Horin.   

Abstract

PURPOSE: Although pseudomembranes are the hallmark manifestation of Clostridium difficile-associated diarrhea (CDAD), there are scant data specifically addressing their impact on the clinical outcome. We investigated whether the formation of pseudomembranes predicts a worse CDAD outcome.
METHODS: CDAD patients hospitalized during 2010 underwent sigmoidoscopy and were followed prospectively. In addition, all hospitalized CDAD patients in the period 01/2000-12/2009 who underwent lower endoscopy were retrospectively identified and their charts reviewed. Patients with detectable pseudomembranes on endoscopy were compared to those in whom pseudomembranes were absent. Thirty-day mortality and a composite outcome comprised of mortality within 30 days of diagnosis, admission to the intensive care unit (ICU), colectomy, peritonitis, hemodynamic instability, or respiratory insufficiency were addressed. Additional clinical outcomes used for comparison between the two groups were 60-day mortality, duration of hospitalization, and the failure of metronidazole and vancomycin.
RESULTS: A total of 117 CDAD patients (mean age 62.9 ± 19 years) who underwent lower endoscopy were included; 46 with pseudomembranes and 71 without. Seven out of the 46 patients with pseudomembranes died within 30 days compared to 9/71 in the non-pseudomembrane group [odds ratio (OR) 1.2, 95% confidence interval (CI) 0.4-3.6, P = 0.8]. Similarly, there was no correlation between the occurrence of pseudomembranes and the rate of the composite adverse outcome (P = 0.6). In contrast, acute renal insufficiency (OR 15, 95% CI 3.2-72, P < 0.001) and hypoalbuminemia (OR 5.7, 95% CI 1.8-18, P = 0.002) were both independently predictive of a severe clinical outcome.
CONCLUSIONS: Our findings suggest that the presence of pseudomembranes is not associated with an adverse outcome in CDAD patients.

Entities:  

Mesh:

Year:  2013        PMID: 23709307     DOI: 10.1007/s15010-013-0473-4

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  22 in total

Review 1.  Clostridium difficile--more difficult than ever.

Authors:  Ciarán P Kelly; J Thomas LaMont
Journal:  N Engl J Med       Date:  2008-10-30       Impact factor: 91.245

2.  Prediction of complicated Clostridium difficile infection by pleural effusion and increased wall thickness on computed tomography.

Authors:  Louis Valiquette; Jacques Pépin; Xuan-Vien Do; Vincent Nault; Andrée-Anne Beaulieu; Justine Bédard; Gérard Schmutz
Journal:  Clin Infect Dis       Date:  2009-08-15       Impact factor: 9.079

3.  Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.

Authors:  Jacques Pépin; Louis Valiquette; Marie-Eve Alary; Philippe Villemure; Annick Pelletier; Karine Forget; Karine Pépin; Daniel Chouinard
Journal:  CMAJ       Date:  2004-08-31       Impact factor: 8.262

4.  Faecal toxin and severity of antibiotic-associated pseudomembranous colitis.

Authors:  D W Burdon; R H George; G A Mogg; Y Arabi; H Thompson; M Johnson; J Alexander-Williams; M R Keighley
Journal:  J Clin Pathol       Date:  1981-05       Impact factor: 3.411

5.  Mortality of patients with antibiotic-associated diarrhoea: the impact of Clostridium difficile.

Authors:  J Bishara; N Peled; S Pitlik; Z Samra
Journal:  J Hosp Infect       Date:  2008-03-19       Impact factor: 3.926

6.  Clinical and microbiological characteristics of community-onset Clostridium difficile infection in The Netherlands.

Authors:  M P Bauer; D Veenendaal; L Verhoef; P Bloembergen; J T van Dissel; E J Kuijper
Journal:  Clin Microbiol Infect       Date:  2009-07-16       Impact factor: 8.067

7.  Absence of pseudomembranes in Clostridium difficile-associated diarrhea in patients using immunosuppression agents.

Authors:  Kenichi Nomura; Yoshiko Fujimoto; Mihoko Yamashita; Yasutaka Morimoto; Muneo Ohshiro; Kazumi Sato; Tatsuo Oyake; Shugo Kowata; Hideyuki Konishi; Toshikazu Yoshikawa; Yoji Ishida; Masafumi Taniwaki
Journal:  Scand J Gastroenterol       Date:  2009       Impact factor: 2.423

8.  Severe Clostridium difficile colitis.

Authors:  M S Rubin; L E Bodenstein; K C Kent
Journal:  Dis Colon Rectum       Date:  1995-04       Impact factor: 4.585

9.  A case-control study of community-associated Clostridium difficile infection.

Authors:  M H Wilcox; L Mooney; R Bendall; C D Settle; W N Fawley
Journal:  J Antimicrob Chemother       Date:  2008-04-22       Impact factor: 5.790

10.  Clinical risk factors for severe Clostridium difficile-associated disease.

Authors:  Timothy J Henrich; Douglas Krakower; Asaf Bitton; Deborah S Yokoe
Journal:  Emerg Infect Dis       Date:  2009-03       Impact factor: 6.883

View more
  5 in total

1.  Prevalence of Nosocominal Toxigenic Clostridium difficile in Children Under 5 Years in Hajar Hospital, Shahrekord, Iran.

Authors:  Abolfazl Khoshdel; Karam-Ali Kasiri; Soleiman Kheiri; Roya Habibian; Narges Shojaeikhah
Journal:  J Clin Diagn Res       Date:  2016-06-01

Review 2.  Clostridium difficile infection: guideline-based diagnosis and treatment.

Authors:  Christoph Lübbert; Endres John; Lutz von Müller
Journal:  Dtsch Arztebl Int       Date:  2014-10-24       Impact factor: 5.594

3.  Association Between Immunosuppressive Therapy and Outcome of Clostridioides difficile Infection: Systematic Review and Meta-Analysis.

Authors:  Yiting Li; Haifeng Cai; Daniel A Sussman; Jean Donet; Kevin Dholaria; Jiajia Yang; Ami Panara; Ryan Croteau; Jamie S Barkin
Journal:  Dig Dis Sci       Date:  2021-09-23       Impact factor: 3.487

Review 4.  A Comparison of Current Guidelines of Five International Societies on Clostridium difficile Infection Management.

Authors:  Csaba Fehér; Josep Mensa
Journal:  Infect Dis Ther       Date:  2016-07-28

Review 5.  Sleeping with the enemy: Clostridium difficile infection in the intensive care unit.

Authors:  Florian Prechter; Katrin Katzer; Michael Bauer; Andreas Stallmach
Journal:  Crit Care       Date:  2017-10-22       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.